局部晚期直肠癌盆腔放疗年轻女性中与早发性卵巢功能不全相关的因素
回顾性分析2001至2019年76例50岁以下局部晚期直肠癌盆腔放疗女性,26例接受卵巢移位。放疗后12个月内25%保留卵巢功能,均来自移位组;移位组卵巢平均剂量1.7 Gy vs 未移位组44.8 Gy(P<.001)。卵巢移位与年龄和早发性卵巢功能不全显著相关(P<.001)。
要点
- 卵巢移位组卵巢平均剂量1.7 Gy vs 未移位组44.8 Gy(P<.001),移位与早发性卵巢功能不全风险降低显著相关(P<.001)。
- 75例随访12个月者中25%保留卵巢功能,全部来自卵巢移位组;移位组19例(76%)保留卵巢功能。
- 卵巢平均剂量低于1.36 Gy者无早发性卵巢功能不全发生;作者建议年轻盆腔放疗患者考虑卵巢移位。
核心结论
- 卵巢移位通过使卵巢接受更低辐射剂量,与早发性卵巢功能不全风险降低显著相关。
- 作者认为年轻盆腔放疗患者应考虑卵巢移位。
- 作者认为卵巢平均剂量与早发性卵巢功能不全似存在显著关联,但需更大规模研究确定剂量学阈值。
- 作者建议在行卵巢移位和盆腔放疗的患者中,将卵巢剂量保持在合理可达到的最低水平。
研究设计与样本
- 回顾性研究,纳入2001年至2019年在本机构因局部晚期直肠癌接受盆腔放疗的50岁以下女性,共76例放疗时处于绝经前状态,中位年龄43岁(范围20-49岁)。
主要发现
- 26例(34%)接受卵巢移位;56例(74%)接受新辅助化疗,69例(91%)接受同步化疗,26例(34%)接受辅助化疗。
- 中位放疗剂量为50 Gy/25次。
- 75例随访满12个月者中,25%保留卵巢功能,全部位于卵巢移位组;卵巢移位组19例(76%)保留卵巢功能。
- 卵巢平均剂量中位数:移位组1.7 Gy vs 未移位组44.8 Gy(P<.001)。
- 卵巢移位和放疗时年龄与早发性卵巢功能不全显著相关(P<.001);卵巢平均剂量低于1.36 Gy者无早发性卵巢功能不全发生。
临床怎么用
- 作者建议年轻盆腔放疗患者考虑卵巢移位。
- 作者建议在行卵巢移位和盆腔放疗的患者中,将卵巢剂量保持在合理可达到的最低水平。
局限性
- 作者指出需要更大规模研究来确定卵巢平均剂量与早发性卵巢功能不全的剂量学阈值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Pelvic radiation therapy (RT) is standard of care for patients with locally advanced rectal cancer (LARC). Premature ovarian insufficiency (POI) in premenopausal women is a possible side effect. The purpose of our study was to evaluate factors associated with POI in women younger than 50 years, treated with pelvic RT for LARC, including those who underwent ovarian transposition (OT). METHODS AND MATERIALS: We retrospectively reviewed the records of women younger than 50 years treated with pelvic RT for LARC at our institution between 2001 and 2019. Clinical and hormonal data were used to determine ovarian function. The ovaries and uterus were contoured and dose volume histograms were generated. Association of clinical and dosimetric factors with POI within 12 months of RT was evaluated using Wilcoxon-rank sum test and Fisher's exact test. RESULTS: We identified 76 premenopausal women at time of RT with median age of 43 years (range, 20-49). Twenty-six women (34%) underwent OT. Neoadjuvant, concurrent, and adjuvant chemotherapy was administered in 56 (74%), 69 (91%), and 26 (34%) women, respectively. Median RT dose was 50 Gy/25 fractions. Among 75 women with 12 months of follow-up, 25% had preservation of ovarian function, all in the OT group. Ovarian function was preserved in 19 (76%) women who underwent OT. The median of ovarian mean dose was 1.7 Gy in the OT group versus 44.8 Gy in the non-OT group (P < .001). OT and age at RT were significantly associated with POI (P < .001). No patient with ovarian mean dose less than 1.36 Gy developed POI. CONCLUSIONS: OT was significantly associated with reduced risk of POI by enabling lower radiation doses to the ovaries. OT should be considered in young patients undergoing pelvic RT. Although there appears to be a significant association between ovarian mean dose and POI, larger studies are needed to find a dosimetric threshold. Our results suggest keeping the dose to the ovaries as low as reasonably achievable in patients who undergo OT and pelvic RT.
引用
- Hilal L, Cercek A, Navilio J, et al. Factors Associated With Premature Ovarian Insufficiency in Young Women With Locally Advanced Rectal Cancer Treated With Pelvic Radiation Therapy. Adv Radiat Oncol. 2021. PMID: 35071829. doi:10.1016/j.adro.2021.100801
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。